P

Inventor

WAHLESTEDT CLAES

CA14 patents
⚠️ This page may combine multiple inventors who share the name “WAHLESTEDT CLAES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CA NAT RESEARCH COUNCIL

3 patents
US7510846B2Mar 31, 2009

Assay employing human or rat GAL-R2 galanin receptor

CA NAT RESEARCH COUNCIL0 citations49
US7407761B2Aug 5, 2008

Methods for assaying expression of novel galanin receptors

CA NAT RESEARCH COUNCIL0 citations49
US7528229B2May 5, 2009

Isolated human and rat GAL-R2 galanin receptors

CA NAT RESEARCH COUNCIL0 citations41

ASTRAZENECA CANADA INC

2 patents
US6680321B1Jan 20, 2004

Compounds with analgesic effect

ASTRAZENECA CANADA INC20 citations92
US6562945B1May 13, 2003

Galanin receptor

ASTRAZENECA CANADA INC0 citations49

WAHLESTEDT CLAES

2 patents
US8288354B2Oct 16, 2012

Natural antisense and non-coding RNA transcripts as drug targets

WAHLESTEDT CLAES33 citations89
US9803195B2Oct 31, 2017

Natural antisense and non-coding RNA transcripts as drug targets

WAHLESTEDT CLAES1 citations60

ROCHE INNOVATION CT COPENHAGEN AS

1 patent
US9738894B2Aug 22, 2017

Short interfering RNA (siRNA) analogues

ROCHE INNOVATION CT COPENHAGEN AS55 citations95

ASTRA PHARMA INC

1 patent
US6130222AOct 10, 2000

Compounds with analgesic effect

ASTRA PHARMA INC40 citations91

ELMEN JOACHIM

1 patent
US8653252B2Feb 18, 2014

Short interfering RNA (siRNA) analogues

ELMEN JOACHIM14 citations83

SANTARIS PHARMA AS

1 patent
US9297010B2Mar 29, 2016

Short interfering RNA (siRNA) analogues

SANTARIS PHARMA AS2 citations60

SCRIPPS RESEARCH INST

1 patent
US10472627B2Nov 12, 2019

Natural antisense and non-coding RNA transcripts as drug targets

SCRIPPS RESEARCH INST0 citations51

UNIV MIAMI

1 patent
US12029706B2Jul 9, 2024

Methods for treating mucopolysaccharidosis

UNIV MIAMI0 citations49

CANADA NAT RES COUNCIL

1 patent
US7375207B2May 20, 2008

Galanin receptor 2 proteins and nucleic acids

CANADA NAT RES COUNCIL0 citations49